Position in TEVA
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,694
+$188 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#634
of 671 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aspect Partners, LLC holds $6,194 across 4 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (27.3% of the industry book) .
All Filings in TEVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,694 | 50 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,506 | 50 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $1,560 | 50 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,010 | 50 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $838 | 50 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $768 | 50 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $1,102 | 50 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,604 | 200 | Shares | Sole | 2024-10-15 | |
| No filing history on record for this holder in this stock. | ||||||